Feds to Publicize Drug and Device Company Payments to Doctors Next Year
” After years of anticipation, all of the nation’s drug and medical device makers must soon begin publicly reporting payments they make to U.S. physicians, according to final regulations announced this month by the federal government. ”
Drugmakers once touted nerve growth factor inhibitors as a potential breakthrough
The power of big pharma and big money! Drug makers often abandon research on experimental drugs that appear to have safety issues but with more than 50 million U.S. adults diagnosed with arthritis the potential multibillion dollar market opportunity may be too big to ignore … Here we go again !!!